About

Publications While At HealthPartners

selected publications

Journal Article

Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. 

Journal of managed care & specialty pharmacy. 2024

Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. 

BMJ Med. 2023

Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. 

JAMA. 2022

Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis. 

BMC Musculoskeletal Disorders. 2022

Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus. 

BMJ open diabetes research & care. 2022

Descriptive analysis of long- and intermediate-acting insulin and key safety outcomes in adults with type 2 diabetes mellitus. 

Journal of managed care & specialty pharmacy. 2019

Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care. 

Journal of managed care & specialty pharmacy. 2019

Contact

full name

C. N. McMahill-Walraven

C. N. McMahill Walraven

Quick Info

 

Collaboration

Co-author network

Map of science